Title |
Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment
|
---|---|
Published in |
Cochrane database of systematic reviews, August 2012
|
DOI | 10.1002/14651858.cd002071.pub3 |
Pubmed ID | |
Authors |
Lindsay Robertson, Maaz A Ghouri, Flora Kovacs |
Abstract |
Peripheral arterial disease (PAD) is frequently treated by balloon angioplasty. Restenosis/reocclusion of the dilated segments occurs often, depending on length of occlusion, lower leg outflow, stage of disease and presence of cardiovascular risk factors. To prevent reocclusion, patients are treated with antithrombotic agents. This is an update of a review first published in 2005. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 50% |
Brazil | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 227 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
United States | 1 | <1% |
Colombia | 1 | <1% |
South Africa | 1 | <1% |
Unknown | 223 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 48 | 21% |
Researcher | 30 | 13% |
Student > Bachelor | 21 | 9% |
Student > Ph. D. Student | 15 | 7% |
Student > Doctoral Student | 12 | 5% |
Other | 32 | 14% |
Unknown | 69 | 30% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 101 | 44% |
Nursing and Health Professions | 16 | 7% |
Agricultural and Biological Sciences | 6 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 3% |
Neuroscience | 5 | 2% |
Other | 15 | 7% |
Unknown | 78 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 March 2020.
All research outputs
#17,351,840
of 25,461,852 outputs
Outputs from Cochrane database of systematic reviews
#10,863
of 12,090 outputs
Outputs of similar age
#124,178
of 186,234 outputs
Outputs of similar age from Cochrane database of systematic reviews
#183
of 218 outputs
Altmetric has tracked 25,461,852 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 12,090 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.2. This one is in the 6th percentile – i.e., 6% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 186,234 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 218 others from the same source and published within six weeks on either side of this one. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.